Authors: RITTER HL GRALLA RJ HALL SW WADA JK FRIEDMAN C HAND L FITTS D

Citation: Hl. Ritter et al., EFFICACY OF INTRAVENOUS GRANISETRON TO CONTROL NAUSEA AND VOMITING DURING MULTIPLE CYCLES OF CISPLATIN-BASED CHEMOTHERAPY, Cancer investigation, 16(2), 1998, pp. 87-93

Authors: PEREZ EA NAVARI RM KAPLAN HG GRALLA RJ GRUNBERG SM PALMER RH FITTS D

Citation: Ea. Perez et al., EFFICACY AND SAFETY OF DIFFERENT DOSES OF GRANISETRON FOR THE PROPHYLAXIS OF CISPLATIN-INDUCED EMESIS, Supportive care in cancer, 5(1), 1997, pp. 31-37

Authors: ETTINGER DS EISENBERG PD FITTS D FRIEDMAN C WILSONLYNCH K YOCOM K

Citation: Ds. Ettinger et al., A DOUBLE-BLIND COMPARISON OF THE EFFICACY OF 2 DOSE REGIMENS OF ORAL GRANISETRON IN PREVENTING ACUTE EMESIS IN PATIENTS RECEIVING MODERATELY EMETOGENIC CHEMOTHERAPY, Cancer, 78(1), 1996, pp. 144-151

Authors: NAVARI R GANDARA D HESKETH P HALL S MAILLIARD J RITTER H FRIEDMAN C FITTS D

Citation: R. Navari et al., COMPARATIVE CLINICAL-TRIAL OF GRANISETRON AND ONDANSETRON IN THE PROPHYLAXIS OF CISPLATIN-INDUCED EMESIS, Journal of clinical oncology, 13(5), 1995, pp. 1242-1248

Authors: TYRING S BARBARASH RA NAHLIK JE CUNNINGHAM A MARLEY J HENG M JONES T REA T BOON R SALTZMAN R BRUCE S HARRIS A EPSTEIN A LOWRY L RUBIN H DUPUY J HENDRICKS J GREER J RAPAPORT M MILLER DJ FRIEDMANN BS SILVERBROOK RM MARLEY W ZELLNER SR MICHIE DD MESTAS F KLUGE R PURVIS QR SCHLEIDER N DOMINGO J SWINEHART JM WILLIAMS K SHULTZ L ROCHAMBEAUM B CAMPBELL D PRICE J KING M MORALEDA P TORO M MORTENSEN M WALKER M STEELE B CASTELLANOS K MILLER C TERRELL MD CRANE J ZINK R SOERRIES S NESTER C NESTER S FOX G CRECELIUS C SINGER M STANTON L ELGART ML MASRIFRIDLING G NOONAN M SCHEINMAN P MCNEELEY MC TURNER M SULICA VI KRAUS SJ GRIFFIN EI KAREMPELIS DS POTTER BC SMITH DM COREY L GILL T RODMAN OG NORUM R BABEL D MARTEL A NESBITT LT LEE BD HEITLER DG HOLLABAUGH E THOMAS JBR JONES CM CANNON TB LITTLEJOHN TW VANZANDT KV SHAR GG BRASWELL SD ROACH JG WORF RC HELLYAR A KATZ HI PRAWER SE LINDHOLM JS HIEN NT FISH FS SCOTT JC KEMPERS S BRIDEN ME LASSONDE M OLIEL V SIMOR A LOW D VELLAND H GOLD W BENEDUM JL GARMONBROWN OE TUCKER WS TAM K LANDIS E BLOUNT CW SPANGENTHAL S CHAPMAN G FISCHER L HADLEY HW GREGSON D HAMMERBERG O FONG I VONBEHREN LA RABINOVICH S KHARDORI N FITTS D GRIER C GRIFFIN D MCKAY D BIRKENMAIER R BISHOP S MARKS GL LOCKE L JUREWICZ R WEILL S MAYEWSKI T FRAZIER C GROSSMAN A MACDONALD J MURPHY P STIEDE K WEIGART MB LEVIDIOTIS M HOSANG M PARSONS J RACHLIS AR SCHACHTER GD SCHACHTER RK GORDON D HALLSWORTH P MARKHAM D WILKINSON E SMITH G WELCH K PIACQUADIO D FLEMING A BRENEMAN DL CHETTY BV MANDERS S LUSHNIAK B HOGAN D REID A TANNOCK G DICK N CROSSLEY L PURVIS R DIVEN D PORTER N HEBERT AA BOWDEN JB SCHULZE KE WILLIAMS KE CONLY JM ANDERSON C SMITH J KRYWONIS N HENG MCY TUCKER R LEE BW WEINTRAUB JS DWYER D HOLLAND D FORDHAM M MILLER G SYLVESTER T MARLOWE SI TANNER ML DILORENZO PA

Citation: S. Tyring et al., FAMCICLOVIR FOR THE TREATMENT OF ACUTE HERPES-ZOSTER - EFFECTS ON ACUTE DISEASE AND POSTHERPETIC NEURALGIA - A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL, Annals of internal medicine, 123(2), 1995, pp. 89-96

Authors: NAVARI RM KAPLAN HG GRALLA RJ GRUNBERG SM PALMER R FITTS D

Citation: Rm. Navari et al., EFFICACY AND SAFETY OF GRANISETRON, A SELECTIVE 5-HYDROXYTRYPTAMINE-3RECEPTOR ANTAGONIST, IN THE PREVENTION OF NAUSEA AND VOMITING INDUCEDBY HIGH-DOSE CISPLATIN, Journal of clinical oncology, 12(10), 1994, pp. 2204-2210